These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 514262)

  • 1. DNA binding studies on several new anthracycline antitumor antibiotics II. The importance of the carbomethoxy-group as position-10 of the class II anthracycline molecule.
    DuVernay VH; Pachter JA; Crooke ST
    Mol Pharmacol; 1979 Sep; 16(2):623-32. PubMed ID: 514262
    [No Abstract]   [Full Text] [Related]  

  • 2. The antitumor effects of anthracyclines. II. The stereospecificity of the carbomethoxy group at position 10 of the class II anthracycline molecule.
    DuVernay VH; Eubanks D; Perales R; Prestayko AW; Crooke ST
    Mol Pharmacol; 1982 Jan; 21(1):196-203. PubMed ID: 6957713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of anthracycline derivatives with DNA: a fluorescence study.
    Valentini L; Nicolella V; Vannini E; Menozzi M; Penco S; Arcamone F
    Farmaco Sci; 1985 Jun; 40(6):377-90. PubMed ID: 3861331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parsing the free energy of anthracycline antibiotic binding to DNA.
    Chaires JB; Satyanarayana S; Suh D; Fokt I; Przewloka T; Priebe W
    Biochemistry; 1996 Feb; 35(7):2047-53. PubMed ID: 8652545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorescence polarization studies of the binding of BMS 181176 to DNA.
    Krishnan BS; Moore ME; Lavoie CP; Long BH; Dalterio RA; Wong HS; Rosenberg IE
    J Biomol Struct Dyn; 1994 Dec; 12(3):625-36. PubMed ID: 7727062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Change of the sequence specificity of daunorubicin-stimulated topoisomerase II DNA cleavage by epimerization of the amino group of the sugar moiety.
    Capranico G; Butelli E; Zunino F
    Cancer Res; 1995 Jan; 55(2):312-7. PubMed ID: 7812964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA.
    Bodley A; Liu LF; Israel M; Seshadri R; Koseki Y; Giuliani FC; Kirschenbaum S; Silber R; Potmesil M
    Cancer Res; 1989 Nov; 49(21):5969-78. PubMed ID: 2551497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Joint experimental and theoretical investigation of the comparative DNA binding affinities of intercalating anthracycline derivatives.
    Gresh N; Pullman B; Arcamone F; Menozzi M; Tonani R
    Mol Pharmacol; 1989 Feb; 35(2):251-6. PubMed ID: 2918856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-cancer activity of anthracycline antibiotics and DNA condensation.
    Cera C; Palumbo M
    Anticancer Drug Des; 1990 Aug; 5(3):265-71. PubMed ID: 2400539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox pathway leading to the alkylation of DNA by the anthracycline, antitumor drugs adriamycin and daunomycin.
    Taatjes DJ; Gaudiano G; Resing K; Koch TH
    J Med Chem; 1997 Apr; 40(8):1276-86. PubMed ID: 9111302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interaction of sibiromycin with DNA: conformational changes and stabilization of DNA helical structure].
    Dudnik IuV; Zimmer K; Liuk G
    Antibiotiki; 1973 Oct; 18(10):895-7. PubMed ID: 4587059
    [No Abstract]   [Full Text] [Related]  

  • 12. [Quantitative determination of anthracycline antibiotic binding with DNA].
    Bogush TA; Baranov EP; Egudina SV; Tankovich NN
    Biull Eksp Biol Med; 1992 Jun; 113(6):636-8. PubMed ID: 1446037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of antitumor antibiotic daunomycin to histones in chromatin and in solution.
    Rabbani A; Finn RM; Thambirajah AA; Ausió J
    Biochemistry; 2004 Dec; 43(51):16497-504. PubMed ID: 15610044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Structure and activity of anthracyclines].
    Lavelle F
    Pathol Biol (Paris); 1987 Jan; 35(1):11-9. PubMed ID: 3550604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deoxyribonucleic acid binding studies on several new anthracycline antitumor antibiotics. Sequence preference and structure--activity relationships of marcellomycin and its analogues as compared to adriamycin.
    DuVernay VH; Pachter JA; Crooke ST
    Biochemistry; 1979 Sep; 18(18):4024-30. PubMed ID: 486409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of daunomycin to diaminopurine- and/or inosine-substituted DNA.
    Bailly C; Suh D; Waring MJ; Chaires JB
    Biochemistry; 1998 Jan; 37(4):1033-45. PubMed ID: 9454594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA topoisomerase II as the primary target of anti-tumor anthracyclines.
    Zunino F; Capranico G
    Anticancer Drug Des; 1990 Nov; 5(4):307-17. PubMed ID: 1963303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substitution at the F-ring N-imide of the indolocarbazole antitumor drug NB-506 increases the cytotoxicity, DNA binding, and topoisomerase I inhibition activities.
    Bailly C; Qu X; Chaires JB; Colson P; Houssier C; Ohkubo M; Nishimura S; Yoshinari T
    J Med Chem; 1999 Jul; 42(15):2927-35. PubMed ID: 10425102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity and DNA-binding property of non-diynene class of dynemicins and aza-anthraquinones.
    Shirai R; Shimazawa R; Shichita M; Takahashi M; Hashimoto Y; Iwasaki S
    Nucleic Acids Symp Ser; 1995; (34):151-2. PubMed ID: 8841597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence-specific DNA interactions by novel alkylating anthracycline derivatives.
    Marchini S; Gonzalez Paz O; Ripamonti M; Geroni C; Bargiotti A; Caruso M; Todeschi S; D'Incalci M; Broggini M
    Anticancer Drug Des; 1995 Dec; 10(8):641-53. PubMed ID: 8595123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.